Effects of chronic haloperidol and/or clozapine on oxidative stress parameters in rat brain

Neurochemical Research

Volumn 32, Issue 8, 2007, Pages 1343-1350

  Agostinho, Fabiano R ^a   Jornada, Luciano K ^a   Schröder, Nadja ^b   Roesler, Rafael ^c   Dal Pizzol, Felipe ^a   Quevedo, João ^a  

^a UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

^b PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Antioxidant enzymes; Clozapine; Haloperidol; Oxidative stress; Peroxidative damage; Reactive oxygen species; Schizophrenia; Tardive dyskinesia

Indexed keywords

CARBONYL DERIVATIVE; CLOZAPINE; HALOPERIDOL; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BRAIN; BRAIN CORTEX; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFECT; HIPPOCAMPUS; LONG TERM EXPOSURE; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIOXIDANTS; ANTIPSYCHOTIC AGENTS; BRAIN; CATALASE; CLOZAPINE; HALOPERIDOL; HUMANS; MALE; OXIDATIVE STRESS; PROTEIN CARBONYLATION; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

ANIMALIA; RATTUS;

EID: 34250815675     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-007-9311-3     Document Type: Article

References (52)

1. Morgenstern H, Glazer WM (1993) Identifying risk factors for tardive dyskinesia among long-term outpatients maintained with neuroleptic medications. Arch Gen Psychiatry 50:723-733
2. Raja M (1995) Tardive dystonia: prevalence, risk factors and comparison with tardive dyskinesia in a population of two hundred acute psychiatric in patients. Eur Arch Psychiatry Clin Neurosci 245:145-151
3. Andreassen OA et al (2003) Oral dyskinesias and histopathological alterations in substantia nigra after long-term haloperidol treatment of old rats. Neuroscience 122:717-725
4. Sachdev P, Saharov T, Cathcart S (1999) The preventive role of antioxidants (selegiline and vitamin E) in a rat model of tardive dyskinesia. Biol Psychiatry 46:1672-1681
5. Jeste DV, Lacro JP, Baily A et al (1999) Lower incidence of tardive dyskinesia with rispiridone compared with haloperidol in older patients. J Am Geriatr Soc 47:716-719
6. Paulson GW (2005) Historical comments on tardive dyskinesia: a neurologist's perspective. J Clin Psychiatry 66:260-264
7. Correll CU, Leucht S, Kane JM (2004) Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies. Am J Psychiatry 161:414-425
8. Westerink BHC, Vries JB (1989) On the mechanism of neuroleptic induced increase in striatal dopamine release: brain dialysis provides direct evidence of mediation by autoreceptors localized on nerve terminals. Neurosci Lett 99:197-202
9. Wayner DDM, Burton GW, Ingold KU et al (1985) Quantitative measurement of the total, peroxyl radical-trapping antioxidant capability of human blood plasma by controlled peroxidation. The important contribution made by plasma proteins. FEBS Lett 187:33-37
10. Yokoyama H, Kasai N, Ueda Y et al (1998) In vivo analysis of hydrogen peroxide and lipid radicals in the striatum of rats under long-term administration of a neuroleptic. Free Radic Biol Med 26:1056-1060
11. Tsai G, Goff DC, Chang RW et al (1998) Markers of glutamatergic neurotransmission and oxidative stress associated with tardive dyskinesia. Am J Psychiatry 155:1207-1213
12. Gupta S, Mosnik D, Black DW et al (1999) Tardive dyskinesia: review of treatments past, present, and future. Ann Clin Psychiatry 11:257-266
13. Soares KV, McGrath JJ (1999) The treatment of tardive dyskinesia-a systematic review and meta-analysis. Schizophr Res 39:1-16
14. Elkashef AM, Wyatt RJ (1999) Tardive dyskinesia: possible involvement of free radicals and treatment with vitamin E. Schizophr Bull 25:731-740
15. Andreassen OA, Jùrgensenb HA (2000) Neurotoxicity associated with neuroleptic-induced oral dyskinesias in rats: implications for tardive dyskinesia? Prog Neurobiol 61:525-541
16. Vilner BJ, DeCosta BR, Bowen WD (1995) Cytotoxic effects of sigma ligants: sigma receptor mediated alteration in cellular morphology and viability. J Neurosci 15:117-134
17. Polydoro M, Schröder N, Noemia M et al (2004) Haloperidol- and clozapine-induced oxidative stress in the rat brain. Pharmacol Biochem Behavior 78:751-756
18. Reinke A, Martins MR, Lima MS et al (2004) Haloperidol and clozapine, but not olanzapine, induces oxidative stress in rat brain. Neurosci Lett 372:157-160
19. Creese I, Burt D, Snyder SH (1976) Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 192:481-483
20. Fang J, Lai CT, Yu PH (1996) Neurotoxic effect of 4-(4-chlorophenyl)-1- (4-(4-fluorophenyl)-4-oxobutyl(-pyridinium) (HP+), a major metabolite of haloperidol in the dopaminergic system in vitro and in vivo. Biog Amines 12:125-134
21. See RE (1991) Striatal dopamine metabolism increases during long-term haloperidol administration in rats but shows tolerance in response to acute challenge with raclopride. Neurosci Lett 129:265-268
22. Shivakumar BR, Ravindranath V (1993) Oxidative stress and thiol modification induced by chronic administration of haloperidol. J Pharmacol Exp Ther 265:1137-1141
23. Tuunainen A, Wahlbeck K, Gilbody S (2002) Newer atypical antipsychotic medication in comparison to clozapine: a systematic review of randomized trials. Schizophr Res 56:1-10
24. Daly DA, Moghaddam B (1993) Actions of clozapine and haloperidol on the extracellular levels of excitotory amino acids in the prefrontal cortex and striatum of conscious rats. Neurosci Lett 152:61-64
25. Bassitt DP, Louza Neto MR (1998) Clozapine efficacy in tardive dyskinesia in schizophrenic patients. Eur Arch Psychiatry Clin Neurosci 248:209-211
26. Parikh V, Khan MM, Mahadik SP (2003) Differential effects of antipsychotics on expression of antioxidant enzymes and membrane lipid peroxidation in rat brain. J Psychiatry Res 37:43-51
27. Gama CS, Salvador M, Andreazza AC et al (2006) Elevated serum superoxide dismutase and thiobarbituric acid reactive substances in schizophrenia: a study of patients treated with haloperidol or clozapine. Prog Neuropsychopharmacol Biol Psychiatry 30:512-515
28. Draper HH, Hadley M (1990) Malondialdehyde determination as index of lipid peroxidation. Methods Enzymol 186:421-431
29. Levine RL, Garland D, Oliver CN (1990) Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 186:464-478
30. Wayner DDM, Burton GW, Ingold KU et al (1985) Quantitative measurement of the total, peroxyl radical-trapping antioxidant capability of human blood plasma by controlled peroxidation. The important contribution made by plasma proteins. FEBS Lett 187:33-37
31. Lowry OH, Rosebrough AL, Randall RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265-275
32. Bannister JV, Calaberese L (1987) Assays for SOD. Methods Biochem Anal 32:279-312
33. Dal-Pizzol F, Klamt F, Bernard EA (2001a) Retinol supplementation induces oxidative stress and modulates antioxidant enzyme activities in rat Sertoli cells. Free Radic Res 34:395-404
34. Dal-Pizzol F, Klamt F, Frota MLC Jr et al (2001b) Neonatal iron exposure induces oxidative stress in adult Wistar rat. Dev Brain Res 130:109-114
35. Cadet JL, Lohr JB, Jeste DV (1986) Free radicals and tardive dyskinesias. Trends Neurosci 9:107-108
36. Creese G, Burt D, Synder SIL (1976) Dopamine receptor binding and pharmacological potencies and antischizophrenic drugs. Science 192:481-483
37. Coyle JT, Puttfarcken P (1993) Oxidative stress glutamate and neurodegenerative disorders. Science 262:689-695
38. Ravindranath V, Reed DJ (1990) Glutathione depletion and formation of glutathione protein mixed disulfide following exposure of brain mitochondria to oxidative stress. Biochem Biophys Res Commun 169:150-158
39. Nielsen EB, Lyon M (1978) Evidence for cell loss in corpus striatum after long-term treatment with a neuroleptic drug (flupenithixol) in rats. Psychopharmacology 59:85-89
40. Subramanyam B, Rollema H, Woolf T (1990) Identification of a potentially neurotoxic pyridinium metabolite of haloperidol in rats. Biochem Biophys Res Commun 166:238-244
41. Chang WH, Jann MW, Chiang TS (1996) Plasma haloperidol and reduced haloperidol concentrations in a geriatric population. Neuropsychobiology 33:12-16
42. Galili R, Mosberg, Gil-Ad I, Weizman A (2000) Haloperidol-induced neurotoxicity-possible implications for tardive dyskinesia. J Neural Transm 107(4):479-490
43. de Leon J, Moral L, Camunas C (1991) Clozapine and jaw dyskinesia: a case report. J Clin Psychiatry 52:494-495
44. Arnaiz SL, Coronel MF, Boveris A (1999) Nitric oxide, superoxide and hydrogen peroxide production in brain mitochondria after haloperidol treatment. Nitric Oxide 3:235-243
45. Dal-Pizzol F, Klamt F, Bernard EA et al (2001) Retinol supplementation induces oxidative stress and modulates antioxidant enzyme activities in rat Sertoli cells. Free Radic Res 34:395-404
46. Dal-Pizzol F, Klamt F, Frota Jr MLC et al (2001) Neonatal iron exposure induces oxidative stress in adult Wistar rat. Dev Brain Res 130:109-114
47. Dal-Pizzol F, Klamt F, Vianna MMR et al (2000) Lipid peroxidation in hippocampus early and late after status epilepticus induced by pilocarpine or kainic acidin Wistar rats. Neurosci Lett 291:179-182
48. Polydoro M, Schröder N, Noemia MM et al (2004) Haloperidol- and clozapine-induced oxidative stress in the rat brain. Pharmacol Biochem Behav 78:751-756
49. Desco M, Gispert JD, Reig S et al (2003) Cerebral metabolic patterns in chronic and recent-onset schizophrenia. Psychiatry Res 122:125-135
50. Halliwell B, Gutteridge JMC (1989) Lipid peroxidation: a radical chain reaction. In: Free radicals biology and medicine, Oxford University Press, New York, pp 188-276
51. Phillis J (1994) ''A radical'' view of cerebral ischemic injury. Prog Neurobiol 42:441-448
52. Frederickson CJ, Cuajungco CJ, Labuda J (2002) Nitric oxide causes apparent release of zinc from presynaptic boutons. Neuroscience 115:471-474